AbbVie Reports New Real-World VRAYLAR Data in Depression
North Chicago, Illinois, September 18, 2026 AbbVie has announced new real-world data for VRAYLAR® (cariprazine) presented at Psych Congress...
AbbVie
Advertisement
Kestrel Therapeutics Gains FDA Fast Track for KST-6051
WATERTOWN, Mass. — September 15, 2026 Kestrel Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has...
Mayo Clinic, Thermo Fisher Launch Precure for Early Signs AI
Rochester, Minnesota, and Waltham, Massachusetts, U.S., September 15, 2026 Mayo Clinic and Thermo Fisher Scientific have launched Precure, LLC,...
Xylo Bio Advances XYL-1001 Phase 1 Trial in Major Depression
Boston, Massachusetts, U.S., September 15, 2026 Xylo Bio, a clinical-stage biotechnology company developing novel neurotherapeutics for psychiatric and neurological...
Allergan Aesthetics Advances Skin Longevity Science Research
Irvine, California, U.S., September 15, 2026 Allergan Aesthetics, an AbbVie company, is preparing to advance scientific discussion around skin...
Advertisements
AbbVie Reports Positive Phase 3 Etentamig Results
North Chicago, Illinois, USA, September 3, 2026 AbbVie has announced positive topline results from the Phase 3 CERVINO trial,...
Summit Therapeutics and Akeso Report Ivonescimab Survival Benefit
Miami, Florida, USA, September 2, 2026 Summit Therapeutics Inc. has reported that its partner Akeso Inc. achieved a statistically...
GT Medical Technologies Expands GammaTile Center Program
Tempe, Arizona, USA, September 2, 2026 GT Medical Technologies has announced Renown Regional Medical Center as the latest institution...
Allergan Aesthetics Reveals Global Layered Beauty Report
North Chicago, Illinois, USA, September 2, 2026 Allergan Aesthetics, an AbbVie company, has unveiled its new “Layered Beauty: The...
PixCell Medical Expands HemoScreen Access Across Canada
Yokneam Illit, Israel, September 2, 2026 PixCell Medical has expanded its international presence into Canada through a strategic partnership...
Advertisement
